SCHEMBL1032212

SCHEMBL1032212

CCCNCCOc1cc(C)c(NS(=O)(=O)c2ccc([C@@H](C)C(F)F)cc2)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.35
MAPT P10636 4/20 0.34
ALDH1A1 P00352 4/20 0.34
NPSR1 Q6W5P4 1/20 0.34
LMNA P02545 4/20 0.33
TSHR P16473 2/20 0.33
HTT P42858 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PIK3C3 Q8NEB9 1/20 0.33
GAA P10253 2/20 0.33
TP53 P04637 2/20 0.33
POLB P06746 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALOX15 P16050 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
FFAR4 Q5NUL3 1/20 0.32
WDR5 P61964 1/20 0.32
F2 P00734 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4242108 0.99 PKM (0.34) PKMMAPTALDH1A1NPSR1LMNA
SCHEMBL1031181 0.90 PIK3C3 (0.41) PKMMAPTALDH1A1NPSR1LMNA
SCHEMBL1031521 0.90 PKM (0.35) PKMMAPTALDH1A1NPSR1LMNA
Hydrochloric Acid SCHEMBL4243272 0.89 PIK3C3 (0.40) PKMMAPTALDH1A1NPSR1LMNA
Hydrochloric Acid SCHEMBL4252359 0.89 PKM (0.35) PKMMAPTALDH1A1NPSR1LMNA
SCHEMBL1029088 0.85 PKM (0.41) PKMMAPTALDH1A1NPSR1LMNA
Hydrochloric Acid SCHEMBL4250907 0.84 PKM (0.40) PKMMAPTALDH1A1NPSR1LMNA
SCHEMBL1028955 0.84 TRPV1 (0.35) PKMMAPTLMNATSHRHTT
Hydrochloric Acid SCHEMBL4241867 0.83 TRPV1 (0.34) PKMMAPTLMNATSHRHTT
SCHEMBL1031369 0.82 FFAR4 (0.48) PKMALDH1A1LMNATSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013179-B1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2011-01-19 EP disclosed